PeptideHub Europe

Executive Summary

PeptideHub Europe, a newer EU-based research peptide supplier, had zero presence on Meta Ads. No pixel installed, no creative assets, and no understanding of how to navigate the platform's strict compliance policies for regulated products. We built their entire Meta Ads infrastructure from scratch — server-side tracking, a library of compliance-first creatives, and a conversion-only campaign strategy designed to drive purchases from day one. No awareness campaigns. No wasted spend on vanity metrics. Within 90 days, PeptideHub Europe scaled from €0 in ad spend to over €95,000/month in revenue, at a 3.9× ROAS and €26.50 CPA.

Brand Overview

PeptideHub Europe is an emerging direct-to-consumer research peptide brand operating across the EU. They offer a curated selection of high-purity compounds with independent Janoshik verification and fast EU-wide shipping. Despite a strong product offering and growing organic presence, they had never explored paid acquisition on Meta.

The Challenge

• No Tracking Infrastructure: no Meta Pixel, no Conversions API, no event tracking.
• No Creative Assets: only product photos, nothing designed for paid media.
• No Compliance Framework for crafting messaging that passes Meta review.
• Fear of Account Bans driven by horror stories in the peptide space.
• Starting Budget: €15,000–€20,000/month with ROI expectations before scaling.

Strategy

1. Tracking & Data Infrastructure

• Meta Pixel with all standard e-commerce events (ViewContent, AddToCart, InitiateCheckout, Purchase).
• Conversions API server-side tracking to bypass iOS 14.5+ limits and ad blockers.
• Event deduplication to prevent double-counting.
• Custom conversions for COA views, purity standards, and research disclaimer acks.
• UTM framework for granular GA4 attribution.

2. Account & Campaign Architecture (Conversion-Only)

3. Audience Strategy

• Broad: Age 25–55, EU, no interest targeting — let the algorithm find buyers.
• Interest stacks: Biochemistry + Molecular Biology + Research Scientist; Biotechnology + Pharma + Lab Equipment; Peptide Research + Amino Acids + Protein Synthesis.
• Lookalikes (post-launch): 1%, 2%, 3% from purchasers after 100+ conversions.
• Retargeting: 7/14-day site visitors, 7-day cart abandoners, 30-day engagers.

4. Creative Strategy

Every creative carried integrated 'FOR RESEARCH PURPOSES ONLY' disclaimers in the visual, not just the copy. Each creative ran 3 primary-text variants for rapid winner identification.

5. Bidding & Optimization

• Lowest Cost during learning → Cost Cap once data accumulated.
• 7-day click, 1-day view attribution window.
• Kill ad sets at 2× CPA target with no conversions; scale at 80% of target by 20% every 48h; refresh creatives at frequency > 2.5.

6. Offer & Landing Page

• Meta-specific landing pages with compliance disclaimers and trust signals.
• 10% first-order discount for Meta traffic.
• Free EU shipping at €75+ to lift AOV.

Execution

• Weeks 1–2 — Infrastructure: tracking, BM, 15 creatives, landing pages.
• Weeks 3–4 — Launch at €500/day. 92% approval rate. Initial CPA €34.20.
• Weeks 5–8 — Scaled to €800/day prospecting + €200/day retargeting. CPA €29.10.
• Weeks 9–12 — Scaled to €1,600–1,800/day. LALs 1/2/3%. CPA €26.50, 3.9× ROAS.

Results

Key Takeaways

1. 01Conversion optimization from day one — skipping awareness let the algorithm find buyers immediately.
2. 02Proper infrastructure is non-negotiable. Pixel + CAPI + events create the data foundation for scale.
3. 03Compliance-first creative wins. Visual disclaimers and research-only messaging produced a 92% approval rate.